Call for Abstracts
We invite researchers, clinicians, and advocates to submit abstracts showcasing innovative studies, clinical trials, and groundbreaking insights in the field of Mucopolysaccharidosis (MPS) and related disorders. Be part of the conversation driving change and progress in the global MPS community.
Guidelines for Submission
Abstracts must adhere to the provided format, including word count limits, structure (background, methods, results, and conclusions), and submission requirements. Detailed instructions are available to ensure your submission meets all criteria for review.
Topics and Categories:
- DIAGNOSTICS AND EARLY DETECTION
- BASIC SCIENCE AND PATHOPHYSIOLOGY
- EMERGING THERAPIES AND TREATMENT INNOVATIONS
- PERSONALIZED AND PRECISION MEDICINE
- CASE REPORTS AND CLINICAL EXPERIENCES
- DIGITAL HEALTH AND TECHNOLOGY INTEGRATION
- CLINICAL RESEARCH AND OUTCOME STUDIES
- PATIENT AND FAMILY EXPERIENCE
- HEALTH SYSTEMS AND POLICY
- CAPACITY BUILDING AND GLOBAL COLLABORATION
Key Dates and Deadlines:
October 1st, 2025 Opening of Abstracts submission
February 1st, 2026 Deadline for abstract submission to MPS2026
March 1st – April 1st, 2026 Late-breaking abstract submission open
February 28th Notification of abstract acceptance for poster or platform presentation at MPS2026
Submission Portal
Submit your abstracts through our easy-to-use online portal. The portal allows you to upload your documents, track submission status, and receive notifications about your application.
Via Paolo Emilio, 7 – 00192 Rome
T. + 39 06.455505560 – info@mps2026.com
Piazza della Vittoria, 29 – 06049 Spoleto (PG) Italy
T. +39 0743.21818 – travel@mps2026.com